1. |
Details of PDMR/person closely associated with them ('PCA') |
a) |
Name |
Mr J Ford |
b) |
Position/status |
SVP & General Counsel |
c) |
Initial notification/ amendment |
Initial notification |
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
GlaxoSmithKline plc |
b) |
LEI |
5493000HZTVUYLO1D793 |
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
a) |
Description of the financial instrument |
GlaxoSmithKline plc American Depositary Shares ('ADSs') ISIN: US37733W1053 |
b) |
Nature of the transaction |
The sale of 11,870 ADSs, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan. |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
$41.22 |
2,679 (Incentive Stock Option) |
$41.22 |
9,191 (Non-Qualified Stock Option) |
|
d) |
Aggregated information Aggregated volume Price |
11,870
$41.22
|
e) |
Date of the transaction |
2019-02-19 |
f) |
Place of the transaction |
New York Stock Exchange (XNYS) |